InspectIR Systems

InspectIR Systems is a U.S.-based medical device and analytical instrumentation company developing portable breath- and air-analysis systems built around miniature mass spectrometry, proprietary hardware, and machine-learning software. The company is best known for the InspectIR COVID-19 Breathalyzer, which received U.S. FDA Emergency Use Authorization as the first COVID-19 diagnostic test using breath samples, and for its broader PNY-1000 platform for point-of-need respiratory screening. InspectIR also markets or develops adjacent applications in narcotics, explosives, and environmental chemical detection through products such as FIDO. Its core value proposition is bringing laboratory-grade chemical analysis into the field without storing biological specimens, enabling rapid screening in healthcare, law enforcement, corrections, and homeland security settings.